A liver disease drug could be repurposed to protect against COVID – new research

By Teresa Brevini, PhD candidate, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge
Fotios Sampaziotis, UKRI Future Leaders Fellow, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge

Almost three years into the pandemic, we’re still regularly seeing hundreds of thousands of new COVID cases recorded each day worldwide. In a new study, involving a combination of miniature organ models, donor organs, animals and humans, we’ve shown that a drug used to treat liver disease could be repurposed to protect against COVID-19.

Vaccines are one of the most potent weapons in our pandemic response, but not everyone can benefit from them. COVID…

Read complete article

~	South Africa’s constitution was set up as the bedrock of its democracy: it’s been challenged over last 30 years, but has held firm

~	‘Polite littering’ is a rubbish problem – here’s why the British approach to tackling clean ups is not working

~	TikTok users claim freezing bread can make it healthier – here’s what the science actually says

~	Purple Hibiscus: Ibrahim Mahama’s Barbican installation wraps the brutalist building in bright cloth and reveals a hidden history

~	Liz Truss’s lessons on how not to be a prime minister

~	Focus on Rwanda’s safety is a distraction from the dangerous conditions for asylum seekers in the UK

~	Think you’ll never retire? Here are four things young people can do to prepare

~	Philadelphia has a lot more deadly shootings than expected for a big city − and NYC is much safer, new study says

~	Cybersecurity researchers spotlight a new ransomware threat – be careful where you upload files

~	Under the influence and under arrest − what happens if you’re drunk in the interrogation room?